Pharma Mar SA
Pharma Mar's GHG Emissions Data Preview
In 2023, Pharma Mar completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Pharma Mar has also provided a category-level breakdown for 3 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Pharma Mar's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Pharma Mar amounted to 3,083 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Pharma Mar increased by 21.95%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Pharma Mar's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Pharma Mar's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Pharma Mar were 1,233 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), Pharma Mar's Scope 1 emissions increased by 6.57%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Pharma Mar's Scope 2 emissions?
In 2023, Pharma Mar reported Scope 2 greenhouse gas (GHG) emissions of 1,850 tCOâ‚‚e using the market-based method.
Has Pharma Mar reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Pharma Mar's Scope 2 emissions (Market-Based) rose by 34.94% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Pharma Mar use for Scope 2 reporting?
In 2023, Pharma Mar reported its Scope 2 emissions using the market-based method.
Pharma Mar's Scope 2 Emissions Over Time
- Total Scope 2 Market-Based
Insights into Pharma Mar's Value Chain Emissions
In 2023, Pharma Mar reported 11,066 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Pharma Mar includes a breakdown across 3 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain
Pharma Mar's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Pharma Mar's Scope 3 emissions?
In 2023, Pharma Mar reported total Scope 3 emissions of 11,066 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 0% of these emissions originated from upstream activities such as purchased goods and capital goods, while 100% came from downstream activities like product use, distribution, and end-of-life treatment.
Compared to the previous year (2022), Pharma Mar's Scope 3 emissions increased by 91.95%, suggesting that the company faced challenges in reducing emissions across its value chain.
What categories of Scope 3 emissions does Pharma Mar disclose?
In 2023, Pharma Mar reported emissions for 3 out of the 15 Scope 3 categories defined by the GHG Protocol.
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
What are the main sources of Pharma Mar's Scope 3 emissions?
In 2023, the largest contributors to Pharma Mar's Scope 3 emissions were:
- Investments (Cat. 15): 7,438 tCOâ‚‚e (81.86%)
- Other/Unspecified Sources: 1,361 tCOâ‚‚e (14.98%)
- Use of Sold Products (Cat. 11): 287 tCOâ‚‚e (3.16%)
Pharma Mar's Scope 3 Emissions by Categories
Insights into Pharma Mar's Total Carbon Footprint
In 2023, Pharma Mar reported a total carbon footprint of 14,149 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 70.61% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Pharma Mar's total carbon footprint was Scope 3 emissions, accounting for 78.21% of the company's total carbon footprint, followed by Scope 2 emissions at 13.08%.